IGF1 and acromegaly: The appropriate PEGV dose varies among acromegaly patients, the Dutch cohort reported that patients using high dose of LA-SSA needed a median weekly PEGV dose of 80 mg (range: 30–300 mg) to achieve normal IGF-I levels in 97 % of the patients [12].